Our investigation revealed that the assessment of the histological subtypes of breast cancer indicated a statistically significant correlation between obesity and lower pCR rates, particularly in HR-positive/HER2-negative patients. This evidence concerns the gene ERBB2 and obesity due to melanocortin 4 receptor deficiency.